Immunomodulatory impact of interferon-alpha in comination with chemoradiation of pancreatic adenocarcinoma (CapRI)

Ähnliche Einträge

• Die CapRI-Studie: Aspekte der Repräsentavität und der externen Validität
  von: Sorg, Carolin
  Veröffentlicht: (2009)
• Enhancement of chemotherapeutic and radio-immunotherapeutic sensitivity on human pancreatic cancer cells due to interferon-alpha (CapRI scheme in vitro)
  von: Ma, Jianhua
  Veröffentlicht: (2004)
• A randomized multicentre phase II trial comparing adjuvant therapy in patients with Interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - CapRI-2
  Veröffentlicht: (2009)
• Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma - CapRI: study protocol (ISRCTN62866759)
  von: Knaebel, Hanns-Peter, et al.
  Veröffentlicht: (2005)
• A phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-fu combined with external radiation treatment (CapRI) versus 5-fu alone for patients with resected pancreatic adenocarinoma: Abschlußbericht
  von: Abel, Ulrich, et al.
  Veröffentlicht: (2010)